vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与SYNCHRONOSS TECHNOLOGIES INC（SNCR）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是SYNCHRONOSS TECHNOLOGIES INC的1.8倍（$75.5M vs $42.0M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -2.2%），SYNCHRONOSS TECHNOLOGIES INC自由现金流更多（$39.0M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Synchronoss Technologies Inc是一家面向全球电信运营商及各行业企业客户，提供云原生数字化转型、用户管理、消息通讯解决方案的科技企业，核心业务覆盖物联网服务赋能、连接入网支持等，市场遍及北美、欧洲及亚太地区。
PBYI vs SNCR — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$42.0M
营收增速更快
PBYI
高出30.0%
-2.2%
自由现金流更多
SNCR
多$24.6M
$14.4M
两年增速更快
PBYI
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $42.0M |
| 净利润 | — | $5.8M |
| 毛利率 | 69.3% | 79.4% |
| 营业利润率 | 22.7% | 14.0% |
| 净利率 | — | 13.8% |
| 营收同比 | 27.7% | -2.2% |
| 净利润同比 | — | 201.7% |
| 每股收益（稀释后） | $0.26 | $0.51 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISNCR
| Q4 25 | $75.5M | — | ||
| Q3 25 | $54.5M | $42.0M | ||
| Q2 25 | $52.4M | $42.5M | ||
| Q1 25 | $46.0M | $42.2M | ||
| Q4 24 | $59.1M | $44.2M | ||
| Q3 24 | $80.5M | $43.0M | ||
| Q2 24 | $47.1M | $43.5M | ||
| Q1 24 | $43.8M | $43.0M |
净利润PBYISNCR
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $5.8M | ||
| Q2 25 | $5.9M | $-19.6M | ||
| Q1 25 | $3.0M | $-3.8M | ||
| Q4 24 | — | $7.9M | ||
| Q3 24 | $20.3M | $-5.7M | ||
| Q2 24 | $-4.5M | $-494.0K | ||
| Q1 24 | $-4.8M | $4.5M |
毛利率PBYISNCR
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | 79.4% | ||
| Q2 25 | 76.5% | 79.0% | ||
| Q1 25 | 77.1% | 79.4% | ||
| Q4 24 | 76.4% | 78.6% | ||
| Q3 24 | 63.9% | 79.1% | ||
| Q2 24 | 77.4% | 76.1% | ||
| Q1 24 | 75.5% | 76.2% |
营业利润率PBYISNCR
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | 14.0% | ||
| Q2 25 | 12.7% | 16.1% | ||
| Q1 25 | 8.7% | 19.5% | ||
| Q4 24 | 22.6% | 16.5% | ||
| Q3 24 | 27.4% | 12.8% | ||
| Q2 24 | -4.6% | 9.9% | ||
| Q1 24 | -5.3% | 10.7% |
净利率PBYISNCR
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 13.8% | ||
| Q2 25 | 11.2% | -46.1% | ||
| Q1 25 | 6.5% | -9.0% | ||
| Q4 24 | — | 17.8% | ||
| Q3 24 | 25.2% | -13.3% | ||
| Q2 24 | -9.6% | -1.1% | ||
| Q1 24 | -11.0% | 10.4% |
每股收益（稀释后）PBYISNCR
| Q4 25 | $0.26 | — | ||
| Q3 25 | $0.17 | $0.51 | ||
| Q2 25 | $0.12 | $-1.87 | ||
| Q1 25 | $0.06 | $-0.37 | ||
| Q4 24 | $0.40 | $0.75 | ||
| Q3 24 | $0.41 | $-0.56 | ||
| Q2 24 | $-0.09 | $0.01 | ||
| Q1 24 | $-0.10 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $34.8M |
| 总债务越低越好 | $22.7M | $163.2M |
| 股东权益账面价值 | $130.3M | $55.4M |
| 总资产 | $216.3M | $278.2M |
| 负债/权益比越低杠杆越低 | 0.17× | 2.95× |
8季度趋势，按日历期对齐
现金及短期投资PBYISNCR
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | $34.8M | ||
| Q2 25 | $96.0M | $24.6M | ||
| Q1 25 | $93.2M | $29.1M | ||
| Q4 24 | $101.0M | $33.4M | ||
| Q3 24 | $96.7M | $25.2M | ||
| Q2 24 | $96.8M | $23.6M | ||
| Q1 24 | $107.2M | $19.1M |
总债务PBYISNCR
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | $163.2M | ||
| Q2 25 | $45.3M | $186.2M | ||
| Q1 25 | $56.7M | $187.0M | ||
| Q4 24 | $68.0M | $186.7M | ||
| Q3 24 | $79.3M | $186.4M | ||
| Q2 24 | $90.7M | $186.2M | ||
| Q1 24 | $102.0M | $136.6M |
股东权益PBYISNCR
| Q4 25 | $130.3M | — | ||
| Q3 25 | $115.3M | $55.4M | ||
| Q2 25 | $104.7M | $49.4M | ||
| Q1 25 | $97.1M | $35.4M | ||
| Q4 24 | $92.1M | $29.8M | ||
| Q3 24 | $71.1M | $35.3M | ||
| Q2 24 | $48.5M | $30.6M | ||
| Q1 24 | $51.0M | $24.0M |
总资产PBYISNCR
| Q4 25 | $216.3M | — | ||
| Q3 25 | $202.9M | $278.2M | ||
| Q2 25 | $194.9M | $291.4M | ||
| Q1 25 | $196.2M | $293.3M | ||
| Q4 24 | $213.3M | $293.8M | ||
| Q3 24 | $220.7M | $299.7M | ||
| Q2 24 | $205.0M | $295.7M | ||
| Q1 24 | $214.1M | $298.5M |
负债/权益比PBYISNCR
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | 2.95× | ||
| Q2 25 | 0.43× | 3.77× | ||
| Q1 25 | 0.58× | 5.28× | ||
| Q4 24 | 0.74× | 6.27× | ||
| Q3 24 | 1.12× | 5.28× | ||
| Q2 24 | 1.87× | 6.08× | ||
| Q1 24 | 2.00× | 5.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $39.4M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $39.0M |
| 自由现金流率自由现金流/营收 | 19.1% | 92.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | 6.77× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $53.1M |
8季度趋势，按日历期对齐
经营现金流PBYISNCR
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | $39.4M | ||
| Q2 25 | $14.1M | $2.3M | ||
| Q1 25 | $3.6M | $293.0K | ||
| Q4 24 | $15.6M | $13.1M | ||
| Q3 24 | $11.0M | $3.4M | ||
| Q2 24 | $1.0M | $11.3M | ||
| Q1 24 | $11.2M | $527.0K |
自由现金流PBYISNCR
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | $39.0M | ||
| Q2 25 | $14.1M | $2.0M | ||
| Q1 25 | $3.6M | $-31.0K | ||
| Q4 24 | $15.6M | $12.2M | ||
| Q3 24 | $11.0M | $3.2M | ||
| Q2 24 | $1.0M | $10.9M | ||
| Q1 24 | — | $10.0K |
自由现金流率PBYISNCR
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | 92.9% | ||
| Q2 25 | 26.8% | 4.6% | ||
| Q1 25 | 7.7% | -0.1% | ||
| Q4 24 | 26.4% | 27.6% | ||
| Q3 24 | 13.7% | 7.5% | ||
| Q2 24 | 2.1% | 25.2% | ||
| Q1 24 | — | 0.0% |
资本支出强度PBYISNCR
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.0% | 1.9% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.9% | ||
| Q1 24 | 0.0% | 1.2% |
现金转化率PBYISNCR
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 6.77× | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | 1.66× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
SNCR
| Subscription Services | $39.4M | 94% |
| Professional Services | $2.6M | 6% |
